The new Bivalent Covid-19 booster vaccine brings no serious safety concerns

The MHRA concluded that the negative effects of the new bivalent vaccination were identical to those of the original Moderna booster dose.

These were described as “usually modest and self-resolving,” and “no significant safety issues were observed.”

Only the AstraZeneca and Janssen vaccines were associated with rare instances of blood clots and abnormal bleeding over the world.

Due to the “high risk” of Covid-related mortality consequences, the MHRA and other health organizations voted in favor of immunization.